OXY

Business Context and Reporting Period

This summary covers the Form 10-Q for Occidental Petroleum Corporation for the quarterly period ended September 30, 2025. Occidental operates through three primary segments: Oil and Gas, Chemical (OxyChem), and Midstream and Marketing. The company is a large accelerated filer with 985.2 million shares of common stock outstanding as of October 31, 2025.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Decline: Net sales decreased 7.7% in Q3 2025 compared to Q3 2024, driven primarily by lower realized crude oil prices (average $64.78/bbl vs $77.06/bbl) and lower chemical product prices.
• Profitability: Net income attributable to common stockholders fell 31% in Q3 2025 and 36% YTD 2025 compared to the prior year periods. The Oil and Gas segment earnings remained relatively stable YTD ($3.93 billion vs $4.04 billion), while the Chemical segment earnings dropped 30% YTD due to lower pricing and higher energy costs.
• Debt Reduction: The company aggressively reduced debt, repaying $1.0 billion in senior notes due 2025, $1.2 billion due 2026, and $1.4 billion of a term loan due 2026 using cash on hand, asset sale proceeds, and warrant exercises.
• Divestitures: Proceeds from asset sales in the first nine months of 2025 totaled approximately $2.2 billion, including sales of Permian Basin working interests and DJ Basin royalties.

Guidance, Outlook, and Material Events

• OxyChem Transaction: In October 2025, Occidental entered into an agreement to sell OxyChem to Berkshire Hathaway for $9.7 billion in an all-cash transaction. The deal is expected to close in Q4 2025. Occidental intends to use the majority of after-tax proceeds to reduce principal debt to below $15 billion. OxyChem will be classified as discontinued operations upon closing.
• Strategic Priorities: Management prioritizes deleveraging, maintaining production base integrity, and delivering a sustainable dividend. The company aims to reduce fixed costs and advance low-carbon ventures.
• Tax Legislation: The "One Big Beautiful Bill Act" (OBBB), enacted July 4, 2025, is expected to significantly reduce 2025 cash tax liabilities through accelerated depreciation and increased tax credits for CO2 projects. Conversely, the Trump Administration paused disbursement of funds under the Inflation Reduction Act (IRA) in January 2025, creating uncertainty regarding clean energy incentives.
• Environmental Liabilities: Total environmental remediation liabilities stood at $1.866 billion as of September 30, 2025. The company retains environmental liabilities for OxyChem's legacy sites post-transaction.
• Warrant Exercise: In April 2025, the company issued 41.9 million shares for approximately $890 million via a warrant exercise offer, proceeds of which were used for debt repayment.

Investor Verification Checklist

• OxyChem Closing Conditions: Verify the status of regulatory approvals required for the $9.7 billion sale to Berkshire Hathaway, as failure to close would impact the company's deleveraging strategy.
• Debt Maturities: Confirm the schedule for remaining debt maturities, specifically the $1.6 billion due in 2026 and the potential put option on Zero Coupon notes in October 2026.
• Commodity Price Sensitivity: Assess the impact of current WTI prices (~$65/bbl) on future cash flows, noting the company's exposure to oil price volatility post-OxyChem divestiture.
• Environmental Reserves: Review the adequacy of the $1.866 billion environmental reserve, particularly regarding the Diamond Alkali Superfund Site (DASS) where estimated costs for remediation could exceed current accruals.
• Tax Rate Volatility: Monitor the final impact of the OBBB and the status of IRA incentives on the effective tax rate, which was 30% YTD 2025.